Inactive Instrument
GW Pharmaceuticals plc Stock London S.E.
Stocks
GB0030544687
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Alkesh Patel
SEC | Corporate Secretary | - | 2024-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
David Spackman
BRD | Director/Board Member | 50 | 2023-01-12 |
Amanda Flanagan
BRD | Director/Board Member | 55 | 2025-02-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | -1.26% | +52.13% | +85.69% | 55.57B | |
| -0.24% | -0.37% | +57.02% | +54.21% | 54.26B | |
| -0.54% | +1.58% | -15.68% | -15.43% | 23.35B | |
| -1.82% | -3.15% | +3.76% | +405.88% | 23.54B | |
| +0.05% | +1.68% | +38.71% | -4.57% | 20.32B | |
| +3.16% | +2.74% | +37.33% | -31.36% | 17.36B | |
| +1.08% | +3.77% | +36.92% | +593.96% | 15.59B | |
| +0.43% | -1.67% | +166.53% | +299.61% | 14.96B | |
| -2.03% | -1.42% | +24.22% | +179.23% | 14.11B | |
| Average | -0.04% | -0.23% | +44.55% | +174.14% | 26.56B | |
| Weighted average by Cap. | -0.18% | -0.23% | +44.16% | +136.09% |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
